Loading...
Market
Eli Lilly Market Share by End of 2026
5
Resolution / Starting Odds
Below 10% • 25%
10% to 15% • 25%
15% to 20% • 25%
Above 20% • 25%
Industry reports on pharmaceutical market share
Story
Eli Lilly Announces $5.3 Billion Investment in Indiana to Expand Drug Manufacturing by 2028
May 24, 2024, 06:42 PM
Eli Lilly announced a $5.3 billion investment to expand manufacturing for its drugs Mounjaro and Zepbound in Indiana. The new facility, which is expected to be operational by 2028, will be the largest site in the U.S. for active pharmaceutical ingredients, according to CEO David Ricks. This investment is part of Eli Lilly's strategy to meet growing demand and capitalize on the expanding market for health-related products. Bank of America has high revenue expectations for Eli Lilly's upcoming drug launches, which Ricks believes are achievable given the current market dynamics.
View original story
Similar markets
Below 10% • 25%
10% - 25% • 25%
25% - 50% • 25%
Above 50% • 25%
Below 15% • 25%
15% to 30% • 25%
30% to 45% • 25%
Above 45% • 25%
<20% • 25%
20%-40% • 25%
40%-60% • 25%
>60% • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than $1 billion • 25%
$1 billion to $5 billion • 25%
$5 billion to $10 billion • 25%
More than $10 billion • 25%
Less than 5% • 33%
5% to 10% • 33%
More than 10% • 34%
Yes • 50%
No • 50%
Less than 10% • 25%
10% to 25% • 25%
26% to 50% • 25%
More than 50% • 25%
Less than 20% • 25%
20%-40% • 25%
40%-60% • 25%
More than 60% • 25%
Less than 10% • 33%
10% to 20% • 33%
More than 20% • 34%
Less than $1 billion • 33%
$1-2 billion • 33%
More than $2 billion • 33%